$NKTR good point from IPCIF board Stopping the Opioid crisis is one of our president's main goals. He recently appointed a new FDA chairman If Trump feels little or no progress is being made to prevent Opioid abuse, he will have no problem shaking up the FDA again. We see how is able to manipulate the Fed chairman and interest rates. The point is this bodes well for an approval come 1/15. I am super bullish on this one!